Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shah

Showing results (451-460 of 498) with videos related to

Pageof 50
Sort By:
BJUI Compass|January 29, 2025
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY studySinan Khadhouri, Kevin Gallagher, Kenneth R MacKenzie, et al.
European Urology|March 22, 2024
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus RecommendationsAlexander Light, Nikhil Mayor, Emma Cullen, et al.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
Contemporary Clinical Trials|April 16, 2026
The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trialArchana Gopalakrishnan, Alexander Light, Nikhil Mayor, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
The Lancet. Oncology|March 3, 2022
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory studyAlistair D R Grey, Rebecca Scott, Bina Shah, et al.
European Urology|November 8, 2025
Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic PathwayChase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al.
Scientific Reports|January 8, 2022
Bedside detection of intracranial midline shift using portable magnetic resonance imagingKevin N Sheth, Matthew M Yuen, Mercy H Mazurek, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Pageof 50

Showing results (451-460 of 498) with videos related to

Sort By:
Pageof 50
BJUI Compass|January 29, 2025
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY studySinan Khadhouri, Kevin Gallagher, Kenneth R MacKenzie, et al.
European Urology|March 22, 2024
The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus RecommendationsAlexander Light, Nikhil Mayor, Emma Cullen, et al.
BJU International|June 29, 2023
External validation of a risk model predicting failure of salvage focal ablation for prostate cancerAlexander Light, Max Peters, Deepika Reddy, et al.
Contemporary Clinical Trials|April 16, 2026
The Imperial Prostate 9 - Approaches To Long-term Active Surveillance: Regular MRI scans versus standard of care (IP9-ATLAS) randomised controlled trialArchana Gopalakrishnan, Alexander Light, Nikhil Mayor, et al.
European Urology|January 21, 2023
Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]Taimur T Shah, Abi Kanthabalan, Marjorie Otieno, et al.
The Lancet. Oncology|March 3, 2022
Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory studyAlistair D R Grey, Rebecca Scott, Bina Shah, et al.
European Urology|November 8, 2025
Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic PathwayChase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al.
Scientific Reports|January 8, 2022
Bedside detection of intracranial midline shift using portable magnetic resonance imagingKevin N Sheth, Matthew M Yuen, Mercy H Mazurek, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
Pageof 50